ZTS (STOCKS)
ZOETIS INC.
$128.068500
-0.061500 (-0.05%)
Prev close: $128.130000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Kristin C. Peck
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57,024.39M
- Employees
- 13,800
- P/E (TTM)
- 21.59
- P/B (TTM)
- 10.48
- Dividend Yield
- 158.43%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $9.40B |
| Benefits Costs and Expenses | $6.07B |
| Cost Of Revenue | $2.66B |
| Costs And Expenses | $6.07B |
| Gross Profit | $6.74B |
| Nonoperating Income/Loss | $47.00M |
| Operating Expenses | $3.41B |
| Selling, General, and Administrative Expenses | $2.38B |
| Other Operating Expenses | $1.02B |
| Operating Income/Loss | $3.33B |
| Income/Loss From Continuing Operations After Tax | $2.65B |
| Income/Loss From Continuing Operations Before Tax | $3.33B |
| Income Tax Expense/Benefit | $680.00M |
| Income Tax Expense/Benefit, Deferred | -$156.00M |
| Interest Expense, Operating | $216.00M |
| Net Income/Loss | $2.65B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $2.65B |
| Net Income/Loss Available To Common Stockholders, Basic | $2.65B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.94 |
| Diluted Earnings Per Share | $5.94 |
| Basic Average Shares | 444,000,000 |
| Diluted Average Shares | 888,648,000 |
| Assets | $15.16B |
| Current Assets | $6.58B |
| Inventory | $2.47B |
| Other Current Assets | $4.12B |
| Noncurrent Assets | $8.58B |
| Fixed Assets | $3.60B |
| Intangible Assets | $1.04B |
| Other Non-current Assets | $3.94B |
| Liabilities | $9.76B |
| Current Liabilities | $1.81B |
| Accounts Payable | $410.00M |
| Wages | $337.00M |
| Other Current Liabilities | $1.06B |
| Noncurrent Liabilities | $7.95B |
| Equity | $5.40B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.40B |
| Liabilities And Equity | $15.16B |
| Net Cash Flow From Operating Activities | $2.92B |
| Net Cash Flow From Operating Activities, Continuing | $2.92B |
| Net Cash Flow From Investing Activities | -$456.00M |
| Net Cash Flow From Investing Activities, Continuing | -$456.00M |
| Net Cash Flow From Financing Activities | -$2.12B |
| Net Cash Flow From Financing Activities, Continuing | -$2.12B |
| Exchange Gains/Losses | $30.00M |
| Net Cash Flow | $370.00M |
| Net Cash Flow, Continuing | $340.00M |
| Comprehensive Income/Loss | $2.68B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.68B |
| Other Comprehensive Income/Loss | $33.00M |